US 12129263
Kinase inhibitors and uses thereof
granted A61PA61P11/00A61P25/00
Quick answer
US patent 12129263 (Kinase inhibitors and uses thereof) held by DENALI THERAPEUTICS INC. expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61P, A61P11/00, A61P25/00, A61P27/02, A61P3/10